Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 4

3(42.9%)

7Total

N/A(4)

Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07004192Phase 4Recruiting

The Role of hCG in Thawed Embryo Transfer

Role: lead

NCT06133803Phase 4Unknown

Lovenox With Aspirin in Thawed Blastocyst Transfer

Role: lead

NCT05498350Not ApplicableUnknown

Randomized Trial Comparing Early "Trigger" Versus Delayed "Trigger" Timing in Cycles of Controlled Ovarian Stimulation.

Role: lead

NCT04096027Phase 4Completed

Cabergoline Before or After Oocyte Collection for Follicular Resolution

Role: lead

NCT00736177Not ApplicableWithdrawn

Comparison of Transfers of Fresh and Thawed Embryos in Patients With Prior Failed Embryo Transfer Cycles

Role: lead

NCT00963625Not ApplicableCompleted

Comparison of Transfers of Fresh and Thawed Embryos in Normal Responder Patients

Role: lead

NCT00963079Not ApplicableCompleted

Comparison of Transfers of Fresh and Thawed Embryos in High Responder Patients

Role: lead

All 7 trials loaded